Elranatamab, A B-Cell Maturation Antigen (Bcma)-Cd3 Bispecific Antibody, For Patients With Relapsed/Refractory Multiple Myeloma: Extended Follow Up And Biweekly Administration From Magnetismm-3
Elranatamab
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: Elranatamab, A B-Cell Maturation Antigen (Bcma)-Cd3 Bispecific Antibody, For Patients With Relapsed/Refractory Multiple Myeloma: Extended Follow Up And Biweekly Administration From Magnetismm-3 ### Output: Elranatamab